Anti–Vascular Endothelial Growth Factor Medications in Retinopathy of Prematurity

Autor:	Julia P Shulman, Ana M Suelves
Rok vydání:	2017
Předmět:	Anti vegf medicine.medical_specialty Bevacizumab business.industry Retinopathy of prematurity medicine.disease 03 medical and health sciences Ophthalmology 0302 clinical medicine 030221 ophthalmology & optometry medicine 030212 general & internal medicine business Optometry medicine.drug
Zdroj:	Advances in Ophthalmology and Optometry. 2:75-86
ISSN:	2452-1760
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::38313df22d85253508d9862823641b15 https://doi.org/10.1016/j.yaoo.2017.03.004 Zobrazit plný text záznamu Full Text from ScienceDirect